Historical record - last NADAC effective date: 4/22/2015
Product Information
SALINE 0.9% SOLN-EXCEL CONT is a generic product labeled by B. Braun Medical Inc., priced at $0.0043 per ML under NDC 00264780000. Its NADAC has been published 129 times since Nov 28, 2013.
FDA first approved this application on Mar 9, 1988. Its Orange Book therapeutic-equivalence code is AP.
Strength
.9 g/100mL
Manufacturer
B. Braun Medical Inc.NDC
00264780000
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAVENOUS
Effective Date
4/22/2015
Active Ingredients
SODIUM CHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA019635FDA Approved
3/9/1988
TE Code
AP
On Market Since
12/31/2013
Pharmacological Classes
Price Statistics
The NADAC for SALINE 0.9% SOLN-EXCEL CONT has been published 129 times since Nov 28, 2013, and over the history we have for it it has risen 184.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0043 per ML |
|---|---|
| All-time high | $0.0043 (May 11, 2016) |
| All-time low | $0.0015 (Nov 28, 2013) |
| Median price | $0.0039 |
| Average price | $0.0034 |
| Largest weekly change | +46.7% (Jan 22, 2014) |
| Weeks tracked | 129 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+184.9%
Last surveyed May 11, 2016 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Sodium Chloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
B. Braun Medical Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Sodium Chloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Osmotic Laxative class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SALINE 0.9% SOLN-EXCEL CONT?
The current National Average Drug Acquisition Cost (NADAC) for SALINE 0.9% SOLN-EXCEL CONT, manufactured by B. Braun Medical Inc., is $0.0043 per ML (NDC 00264780000), effective May 11, 2016.
How has the price of SALINE 0.9% SOLN-EXCEL CONT changed over time?
Over the history we have for it, the NADAC for SALINE 0.9% SOLN-EXCEL CONT has risen 184.9%. It has been tracked across 129 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for SALINE 0.9% SOLN-EXCEL CONT?
Since Nov 28, 2013, the NADAC for SALINE 0.9% SOLN-EXCEL CONT has ranged from a low of $0.0015 (Nov 28, 2013) to a high of $0.0043 (May 11, 2016), with a median of $0.0039 per ML.
Are there cheaper alternatives to SALINE 0.9% SOLN-EXCEL CONT?
No other NADAC-published product currently shares the active ingredient and strength of SALINE 0.9% SOLN-EXCEL CONT in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures SALINE 0.9% SOLN-EXCEL CONT?
SALINE 0.9% SOLN-EXCEL CONT (NDC 00264780000) is labeled by B. Braun Medical Inc., and CMS classifies it as a generic product.